Michael A. Badgley

Statistics

Publications

Citations

2.1K

H-Index

Active since

2017

Affiliations

Columbia University Irving Medical Center(Current)

Columbia University

Harvard University

Children's Medical Center

Brigham and Women's Hospital

Michael A. Badgley is an author at Columbia University Irving Medical Center specializing in oncology, molecular oncology, and metabolic reprogramming.

ORCID

Publications per year

2017–2024

Publications

Cysteine depletion induces pancreatic tumor ferroptosis in mice

Michael A. Badgley, Daniel M. Kremer, H. Carlo Maurer et al. · Science · 2020 · 1.3K citations · Full text

Medicine, Cancer Biology, Oncology +15

Multivalent Small-Molecule Pan-RAS Inhibitors

Matthew Welsch, Anna Kaplan, Jennifer M. Chambers et al. · Cell · 2017 · 283 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis

Daniel M. Kremer, Barbara Scott Nelson, Lin Lin et al. · Nature Communications · 2021 · 256 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton et al. · Nature · 2024 · 175 citations · Full text

Medicine, Oncology, Pharmacology +17

Adaptive stimulation of macropinocytosis overcomes aspartate limitation in cancer cells under hypoxia

Javier García‐Bermúdez, Michael A. Badgley, Sheela Prasad et al. · Nature Metabolism · 2022 · 75 citations · Full text

Medicine, Cell Biology, Oncology +16

1–5 of 6